Alto Neuroscience Inc.

4.29
-0.01 (-0.23%)
At close: Jan 28, 2025, 3:59 PM
4.27
-0.35%
After-hours Jan 28, 2025, 07:00 PM EST

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22 FY21
Net Income -36.30M -27.71M -9.19M
Depreciation & Amortization 373.00K 342.00K 145.00K
Stock-Based Compensation 2.89M 1.76M 227.00K
Other Working Capital -391.00K 2.42M 255.00K
Other Non-Cash Items 291.00K 915.00K 1.47M
Deferred Income Tax n/a n/a n/a
Change in Working Capital -698.00K 4.58M -572.00K
Operating Cash Flow -33.45M -20.39M -9.26M
Capital Expenditures -470.00K -732.00K -680.00K
Acquisitions n/a n/a n/a
Purchase of Investments n/a n/a n/a
Sales Maturities Of Investments n/a n/a n/a
Other Investing Acitivies n/a n/a n/a
Investing Cash Flow -470.00K -732.00K -680.00K
Debt Repayment n/a 9.82M n/a
Common Stock Repurchased n/a n/a n/a
Dividend Paid n/a n/a n/a
Other Financial Acitivies 67.95M 33.92M 31.68M
Financial Cash Flow 68.13M 43.79M 31.69M
Net Cash Flow 34.20M 22.64M 21.70M
Free Cash Flow -33.92M -21.13M -9.94M